Leveraging a Previously Published Population Pharmacokinetic Model to Predict Rivaroxaban Exposure in Real‐World Patients-Reference-Cited by-同舟云学术

Leveraging a Previously Published Population Pharmacokinetic Model to Predict Rivaroxaban Exposure in Real‐World Patients

Published:2022-07-25 Issue:12 Volume:62 Page:1518-1527
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharma

Author:

Weiner Daniel¹,Powell J. Robert¹,Patterson J. Herbert¹,Tyson Rachel¹,Gehi Anil²,Moll Stephan³,Konicki Robyn¹,Qaraghuli Farah Al⁴,Campbell Kristen B.⁵,Kashuba Angela D.M.¹,Gonzalez Daniel¹^ORCID

Affiliation:

1. Division of Pharmacotherapy and Experimental Therapeutics UNC Eshelman School of Pharmacy The University of North Carolina at Chapel Hill Chapel Hill North Carolina USA

2. Division of Cardiology Department of Medicine The University of North Carolina at Chapel Hill Chapel Hill North Carolina USA

3. Division of Hematology Department of Medicine The University of North Carolina at Chapel Hill Chapel Hill North Carolina USA

4. Cognigen Corporation Buffalo New York USA

5. Department of Pharmacy Duke University Hospital Durham North Carolina USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.2122

Reference11 articles.

1. Model-Based Drug Development Survey Finds Pharmacometrics Impacting Decision Making in the Pharmaceutical Industry

2. Methods and strategies for assessing uncontrolled drug–drug interactions in population pharmacokinetic analyses: results from the International Society of Pharmacometrics (ISOP) Working Group

3. Integrated Population Pharmacokinetic Analysis of Rivaroxaban Across Multiple Patient Populations

4. Rivaroxaban Precision Dosing Strategy for Real‐World Atrial Fibrillation Patients

5. Janssen Pharmaceutical Companies.Xarelto (rivaroxaban) [package insert]. U.S. Food and Drug Administration website.https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022406s028lbl.pdf. Revised June 2018. Accessed May 23 2021.